During the past decade, Sentara Medical Group conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 13 clinical trials were completed, i.e. on average, 108.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 6 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sentara Medical Group" #1 sponsor was "W.L.Gore & Associates" with 6 trials, followed by "Hoffmann-La Roche" with 4 trials sponsored, "Complexa, Inc." with 2 trials sponsored, "Proteon Therapeutics" with 2 trials sponsored and "Terumo Medical Corporation" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sentara Medical Group" #1 collaborator was "Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)" with 2 trials as a collaborator, "Innovative Analytics" with 2 trials as a collaborator, "Medpace, Inc." with 2 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 2 trials as a collaborator and "Bard Ltd" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Sentara Medical Group" are "Alzheimer's Disease" (4 trials), "Aortic Aneurysm, Thoracic" (2 trials), "Chronic Kidney Disease" (2 trials), "PAH" (2 trials) and "Rheumatoid Arthritis" (2 trials). Many other conditions were trialed in "Sentara Medical Group" in a lesser frequency.

Most popular intervention types in "Sentara Medical Group" are "Drug" (14 trials), "Device" (9 trials), "Other" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Crenezumab" (3 trials), "GORE® TAG® Thoracic Branch Endoprosthesis" (2 trials), "PRT-201" (2 trials) and "150mg CXA-10" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sentara Medical Group" are 24 trials for "All" genders.

Currently, there are NaN active trials in "Sentara Medical Group". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Sentara Medical Group, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Sentara Medical Group, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 8 trials that are defined as “Not Applicable".